Synopsis of recent research by authors named "Nalini Marino"
- Nalini Marino's research primarily focuses on the development of oncolytic viruses as a therapeutic platform for cancer treatment, specifically addressing the challenge of genetically modifying these viruses to express therapeutic transgenes without compromising their efficacy or safety in patients.
- A notable publication from Marino discusses the development of enadenotucirev, an oncolytic adenovirus, which aims to enhance cancer targeting and treatment outcomes by allowing for local intra-tumoral expression of therapeutic genes.
- The findings emphasize the potential of engineered oncolytic viruses to not only selectively kill tumor cells but also deliver additional therapeutic benefits, thereby improving the overall approach to cancer therapy.
